ROG ROGERS CORP
Plastic Materials, Synth Resins & Nonvulcan Elastomers · NYSE · SEC CIK 84748 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY6.7%
TTM net income YoY167.7%
TTM EPS YoY168.3%
Revenue 3-yr CAGR-2.7%
Net income 3-yr CAGR-23.4%
Margins
Gross margin32.7%
Operating margin7.9%
Net margin5.3%
FCF margin11.3%
EBITDA margin14.3%
Returns
ROE3.7%
ROA3.1%
ROIC (approx.)4.1%
Asset turnover0.59x
Leverage & solvency
Liabilities / assets16.3%
Debt / equity0.00x
Current ratio4.14x
Interest coverage—
Cash quality & payout
Operating cash flow / net income2.62x
Accruals ratio-5.0%
Payout ratio—
Capex / revenue2.5%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $810.80M | $830.10M |
| Cost of revenue | $554.00M | $553.00M |
| Gross profit | $256.80M | $277.10M |
| R&D expense | $28.10M | $34.60M |
| SG&A expense | $176.60M | $193.40M |
| Operating income | -$45.00M | $24.90M |
| Pretax income | -$45.10M | $34.30M |
| Income tax | $16.70M | $8.20M |
| Net income | -$61.80M | $26.10M |
| EBITDA | $9.30M | $74.30M |
| EPS (basic) | -3.40 | 1.40 |
| EPS (diluted) | -3.40 | 1.40 |
| Weighted avg. shares (diluted) | 18.20M | 18.60M |
| Banking | ||
| Net interest income | $800,000 | -$800,000 |
| Balance sheet | ||
| Cash & equivalents | $197.00M | $159.80M |
| Short-term investments | $0 | — |
| Receivables | $130.60M | $135.30M |
| Inventory | $125.00M | $142.30M |
| Current assets | $500.00M | $493.90M |
| PP&E, net | $372.40M | $365.10M |
| Goodwill | $303.40M | $357.60M |
| Intangibles | $99.30M | $110.30M |
| Total assets | $1.43B | $1.48B |
| Current liabilities | $126.10M | $123.50M |
| Long-term debt | — | $0 |
| Total debt | — | $0 |
| Total liabilities | $234.20M | $229.50M |
| Shareholders' equity | $1.20B | $1.25B |
| Net debt | — | -$159.80M |
| Shares outstanding | 17.80M | 18.50M |
| Cash flow statement | ||
| Operating cash flow | $101.20M | $127.10M |
| Capital expenditure | $30.10M | $56.10M |
| Free cash flow | $71.10M | $71.00M |
| Investing cash flow | -$14.80M | -$45.60M |
| Financing cash flow | -$53.90M | -$50.10M |
| Depreciation & amortization | $54.30M | $49.40M |
| Stock-based compensation | $10.90M | $15.10M |
| Share buybacks | $52.40M | $19.80M |
Free plan shows the latest 2 periods; Pro shows all 17 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.